EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine

Heying Yao, Fan Zheng, Yan Zhong, Huanfeng Tian, Zhiyan Li, Hua Zhu, Zhi Yang iD, Hong Zhang, Mei Tian, Wenbin Zeng iD

Molecular Pharmaceutics · 04.05.2026 · 23 (5) · 2829-2847

DOI: 10.1021/acs.molpharmaceut.6c00111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, online erschienen am 31.03.2026. Verfasst von Heying Yao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, PR China. Hauptthemen laut MEDLINE: Boron Neutron Capture Therapy, Heavy Ion Radiotherapy, Neoplasms, Drug Delivery Systems. Die Arbeit nennt 128 Literaturangaben. Gefördert von: Department of Science and Technology of Hunan Province, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Boron Neutron Capture TherapyHeavy Ion RadiotherapyNeoplasmsDrug Delivery SystemsHumansPrecision MedicineProton Therapy

Stichwörter der Autor:innen

Bragg peakboron neutron capture therapycarbon ion radiotherapydual-targeting innovationparticle radiotherapyproton therapy

Autor:innen und Institutionen

  • Xiangya School of Pharmaceutical Sciences, Central South University, Changsha 410013, PR China.
  • Hunan Key Laboratory of Diagnostic and Therapeutic Drug Research for Chronic Diseases, Central South University, Changsha 410013, PR China.
  • Zhejiang Cancer Hospital, The Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang 310000, China.
  • Department of Nuclear Medicine, State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Beijing Key Laboratory of Carcinogenesis and Translational Research, Peking University Cancer Hospital…
  • Huashan Hospital & Human Phenome Institute, Fudan University, 825 Zhangheng Road, Shanghai 201203, China.

ORCID-Profile: Zhi Yang, Wenbin Zeng

Förderung

  • Department of Science and Technology of Hunan Province
  • National Natural Science Foundation of China

Zitieren

APA

Yao, H., Zheng, F., Zhong, Y., Tian, H., Li, Z., Zhu, H., Yang, Z., Zhang, H., Tian, M., & Zeng, W. (2026). Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine. Molecular Pharmaceutics, 23(5), 2829-2847. https://doi.org/10.1021/acs.molpharmaceut.6c00111

Vancouver

Yao H, Zheng F, Zhong Y, Tian H, Li Z, Zhu H, et al. Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine. Molecular Pharmaceutics. 2026;23(5):2829-2847. doi:10.1021/acs.molpharmaceut.6c00111

BibTeX
@article{Yao2026,
  author = {Yao, Heying and Zheng, Fan and Zhong, Yan and Tian, Huanfeng and Li, Zhiyan and Zhu, Hua and Yang, Zhi and Zhang, Hong and Tian, Mei and Zeng, Wenbin},
  title = {Evolution of Particle Radiotherapy: From Physical to Dual Targeting in Precision Medicine},
  journal = {Molecular Pharmaceutics},
  year = {2026},
  volume = {23},
  number = {5},
  pages = {2829--2847},
  doi = {10.1021/acs.molpharmaceut.6c00111}
}
Kostenlos starten →